Abstract

This policy statement revises a previous statement on screening of preterm infants for retinopathy of prematurity (ROP) that was published in 2013. ROP is a pathologic process that occurs in immature retinal tissue and can progress to a tractional retinal detachment, which may then result in visual loss or blindness. For more than 3 decades, treatment of severe ROP that markedly decreases the incidence of this poor visual outcome has been available. However, severe, treatment-requiring ROP must be diagnosed in a timely fashion to be treated effectively. The sequential nature of ROP requires that infants who are at-risk and preterm be examined at proper times and intervals to detect the changes of ROP before they become destructive. This statement presents the attributes of an effective program to detect and treat ROP, including the timing of initial and follow-up examinations.

Keywords

Retinopathy of prematurityMedicineChildhood blindnessBlindnessPediatricsIncidence (geometry)Intensive care medicineGestational ageOptometryPregnancy

Affiliated Institutions

Related Publications

Publication Info

Year
2018
Type
review
Volume
142
Issue
6
Citations
1373
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1373
OpenAlex

Cite This

Walter M. Fierson, Michael F. Chiang, William V. Good et al. (2018). Screening Examination of Premature Infants for Retinopathy of Prematurity. PEDIATRICS , 142 (6) . https://doi.org/10.1542/peds.2018-3061

Identifiers

DOI
10.1542/peds.2018-3061